JP2008514563A5 - - Google Patents

Download PDF

Info

Publication number
JP2008514563A5
JP2008514563A5 JP2007532823A JP2007532823A JP2008514563A5 JP 2008514563 A5 JP2008514563 A5 JP 2008514563A5 JP 2007532823 A JP2007532823 A JP 2007532823A JP 2007532823 A JP2007532823 A JP 2007532823A JP 2008514563 A5 JP2008514563 A5 JP 2008514563A5
Authority
JP
Japan
Prior art keywords
mic
test results
table below
antibacterial test
typical antibacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007532823A
Other languages
English (en)
Japanese (ja)
Other versions
JP4887297B2 (ja
JP2008514563A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/010154 external-priority patent/WO2006032466A2/en
Publication of JP2008514563A publication Critical patent/JP2008514563A/ja
Publication of JP2008514563A5 publication Critical patent/JP2008514563A5/ja
Application granted granted Critical
Publication of JP4887297B2 publication Critical patent/JP4887297B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007532823A 2004-09-24 2005-09-20 新規二環式抗生物質 Expired - Fee Related JP4887297B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EPPCT/EP2004/010762 2004-09-24
EP2004010762 2004-09-24
EP2005007731 2005-07-15
EPPCT/EP2005/007731 2005-07-15
PCT/EP2005/010154 WO2006032466A2 (en) 2004-09-24 2005-09-20 New bicyclic antibiotics

Publications (3)

Publication Number Publication Date
JP2008514563A JP2008514563A (ja) 2008-05-08
JP2008514563A5 true JP2008514563A5 (enExample) 2011-12-08
JP4887297B2 JP4887297B2 (ja) 2012-02-29

Family

ID=36090370

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007532823A Expired - Fee Related JP4887297B2 (ja) 2004-09-24 2005-09-20 新規二環式抗生物質

Country Status (5)

Country Link
JP (1) JP4887297B2 (enExample)
AR (1) AR050958A1 (enExample)
CA (1) CA2580621A1 (enExample)
TW (1) TW200615267A (enExample)
WO (1) WO2006032466A2 (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1845995A4 (en) 2005-01-25 2010-03-03 Glaxo Group Ltd ANTIBACTERIAL AGENTS
KR20080016577A (ko) * 2005-05-24 2008-02-21 아스트라제네카 아베 항균 활성을 갖는 아미노피페리딘 퀴놀린 및 이들의아자이소스테릭 유사체
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
JP2009524643A (ja) 2006-01-26 2009-07-02 アクテリオン ファーマシューティカルズ リミテッド テトラヒドロピラン抗生物質
DE602007010427D1 (de) 2006-02-15 2010-12-23 Actelion Pharmaceuticals Ltd Antibiotische ethanol- oder 1,2-ethandiol-cyclohexyl-derivate
CA2643962A1 (en) * 2006-03-10 2007-09-20 Actelion Pharmaceuticals Ltd Antibiotic compounds
ATE481406T1 (de) 2006-04-06 2010-10-15 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
TW200815425A (en) * 2006-06-08 2008-04-01 Speedel Experimenta Ag 2,5-disubstituted piperidines
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
TW200819457A (en) * 2006-08-30 2008-05-01 Actelion Pharmaceuticals Ltd Spiro antibiotic derivatives
CL2007003693A1 (es) * 2006-12-22 2008-06-27 Actelion Pharmaceuticals Ltd Compuestos derivados de pirido [3,2-b] [1,4] tiazina; composicion farmaceutica que contiene dichos compuestos; y su uso en el tratamiento de infecciones bacterianas.
CL2008001003A1 (es) 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
CL2008001002A1 (es) 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
PT2137196E (pt) 2007-04-20 2010-12-16 Glaxo Group Ltd Compostos tricíclicos contendo azoto como agentes antibacterianos
CA2689102C (en) * 2007-06-15 2016-07-26 Actelion Pharmaceuticals Ltd 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
EP2005995A1 (en) * 2007-06-22 2008-12-24 Glaxo Group Limited Heterocyclic compounds for the treatment of tuberculosis
JP5323088B2 (ja) 2007-12-18 2013-10-23 アクテリオン ファーマシューティカルズ リミテッド 5−アミノシクリルメチル−オキサゾリジン−2−オン誘導体
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
BRPI0907892A2 (pt) 2008-02-20 2015-07-28 Actelion Pharmaceuticals Ltd Composto antibiótico azatricíclico, medicamento, composição farmacêutica que o contém e uso do mesmo
WO2009128019A1 (en) 2008-04-15 2009-10-22 Actelion Pharmaceuticals Ltd Tricyclic antibiotics
AU2009254738B2 (en) 2008-06-03 2014-05-08 Idorsia Pharmaceuticals Ltd [4-(1-amino-ethyl) -cyclohexyl] -methyl-amine and [6-(1-amino-ethyl) -tetrahydro- pyran-3-yl] -methyl-amine derivatives as antibacterials
WO2010015985A1 (en) 2008-08-04 2010-02-11 Actelion Pharmaceuticals Ltd Tricyclic alkylaminomethyloxazolidinone derivatives
JP4833385B1 (ja) 2008-10-07 2011-12-07 アクテリオン ファーマシューティカルズ リミテッド 三環式オキサゾリジノン抗生物質化合物
JP2012505866A (ja) 2008-10-17 2012-03-08 グラクソ グループ リミテッド 抗菌剤として使用される三環式窒素化合物
RS52809B (sr) 2008-11-17 2013-10-31 F. Hoffmann-La Roche Ag. Naftilsirćetne kiseline
CN102232078B (zh) * 2008-12-12 2014-07-16 埃科特莱茵药品有限公司 5-氨基-2-(1-羟基-乙基)-四氢吡喃衍生物
US8318940B2 (en) 2009-01-15 2012-11-27 Glaxo Group Limited Naphthyridin-2 (1 H)-one compounds useful as antibacterials
US8716280B2 (en) 2009-01-21 2014-05-06 Basilea Pharmaceutica Ag Bicyclic antibiotics
AR076222A1 (es) 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen
BR112013007566A2 (pt) 2010-09-28 2016-08-02 Panacea Biotec Ltd novos compostos bicíclicos
TR201807311T4 (tr) 2011-03-10 2018-06-21 Daiichi Sankyo Co Ltd Dispiropirolidin derivesi.
EP2685828A4 (en) * 2011-03-17 2014-08-13 Merck Sharp & Dohme SUBSTITUTED 3-AZABICYCLO [3,1,0-] HEXAN DERIVATIVES AS CCR2 ANTAGONISTS
US8829191B2 (en) * 2011-06-17 2014-09-09 Melanie Simone Ronsheim Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
JP2014518267A (ja) * 2011-06-27 2014-07-28 杏林製薬株式会社 細菌感染症の治療のための架橋二環式化合物
US8470884B2 (en) 2011-11-09 2013-06-25 Hoffmann-La Roche Inc. Alkenyl naphthylacetic acids
TW201326180A (zh) 2011-11-30 2013-07-01 Actelion Pharmaceuticals Ltd 3,7-二取代八氫-2H-吡啶并[4,3-e][1,3]□嗪-2-酮抗生素
AR101674A1 (es) 2014-08-22 2017-01-04 Glaxosmithkline Ip Dev Ltd Uso de un compuesto tricíclico que contiene nitrógeno
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
TW201920129A (zh) 2017-09-01 2019-06-01 美商戴納立製藥公司 化合物、組合物及方法
MY202326A (en) 2017-09-14 2024-04-24 Daiichi Sankyo Co Ltd Compound having cyclic structure
CN109082280B (zh) * 2018-11-05 2020-07-28 宁夏中星显示材料有限公司 一种液晶材料的制备方法
EP3924341A4 (en) 2019-02-13 2022-11-02 Denali Therapeutics Inc. Compounds, compositions and methods
TW202241857A (zh) 2020-12-18 2022-11-01 美商戴納立製藥公司 化合物之固體形式

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004089942A2 (en) * 2001-10-02 2004-10-21 Acadia Pharmaceuticals Inc. Benzimidazolidinone derivatives as muscarinic agents
JP4445753B2 (ja) * 2002-01-29 2010-04-07 グラクソ グループ リミテッド アミノピペリジン誘導体
AR040336A1 (es) * 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
AR040335A1 (es) * 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de ciclohexano o ciclohexeno, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento y compuestos intermediarios de utilidad para preparar dicho compuesto
DE10256405A1 (de) * 2002-12-02 2004-06-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen, die Topoisomerase IV inhibieren
JP4602903B2 (ja) * 2002-10-10 2010-12-22 モルフォケム アクチェンゲゼルシャフト フュア コンビナトリシェ ヘミー 抗菌活性を有する新規化合物
DE10316081A1 (de) * 2003-04-08 2004-10-21 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
WO2006012396A1 (en) * 2004-07-22 2006-02-02 Glaxo Group Limited Antibacterial agents
DE102004041163A1 (de) * 2004-08-25 2006-03-02 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität

Similar Documents

Publication Publication Date Title
JP2008512492A5 (enExample)
JP2005194118A5 (enExample)
JP2006257115A5 (enExample)
JP2008542211A5 (enExample)
JP2005261231A5 (enExample)
JP2008512398A5 (enExample)
JP2007514712A5 (enExample)
JP2009506999A5 (enExample)
JP2007520206A5 (enExample)
JP2007505861A5 (enExample)
JP2005120465A5 (enExample)
JP2006063441A5 (enExample)
JP2007119645A5 (enExample)
JP2006045672A5 (enExample)
JP2007500762A5 (enExample)
JP2005095148A5 (enExample)
JP2006101735A5 (enExample)
JP2005290409A5 (enExample)
JP2008525570A5 (enExample)
JP2006523255A5 (enExample)
JP2007526266A5 (enExample)
JP2008524415A5 (enExample)
JP2006273834A5 (enExample)
JP2007001784A5 (enExample)
JP2008525527A5 (enExample)